![](/img/cover-not-exists.png)
831TiPA phase III, randomized, double-blind, placebo-controlled, international study of durvalumab in combination with gemcitabine plus cisplatin for patients with advanced biliary tract cancers: TOPAZ-1
Oh, D-Y, Chen, L-T, He, A R, Okusaka, T, Qin, S, Chin, S, Rokutanda, N, Uchinda, H, Vogel, A, Valle, J W, Kim, HVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.157
Date:
October, 2019
File:
PDF, 76 KB
2019